Crossmark

NAD+ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway

Crossref DOI link: https://doi.org/10.1186/s12974-021-02250-8

Published Online: 2021-09-16

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Yao

Zhang, Jiawei

Zheng, Yaling

Zhang, Yaxuan

Zhang, Xiao Jie

Wang, Hongmei

Du, Yu

Guan, Jian

Wang, Xiuzhe

Fu, Jianliang http://orcid.org/0000-0003-1749-461X
Funding

Funding for this research was provided by:

national natural science foundation of china (81871103, 81870952, 81974158)
License Information

Text and Data Mining valid from 2021-09-16

Version of Record valid from 2021-09-16
More Information

Article History

Received: 14 June 2021

Accepted: 24 August 2021

First Online: 16 September 2021

Declarations

:

: All the animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital.

: Written informed consent for publication was obtained from all the authors.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below